FinTechFunding

BioGenCell: Completes $16M in Seed Funding

BioGenCell Completes $16M in Seed Funding

  • BioGenCell, a Netanya, Israel-based biotechnology company, raised $16M in Seed funding
  • The round was led by Marius Nacht
  • The company intends to use the funds to accelerate its development efforts
  • The company  is a biotechnology company that develops technology for using stem cells from the patient’s own blood to treat microvascular diseases
  • Bio GenCell’s medical platform focuses on the needs of patients and physicians
  • The current product treats severe limb-threatening ischemia (CLI) typically found in patients with diabetes and heavy smokers
Previous article
BridgerPay: Raises $6M in Seed Funding
Next article
Quality Clouds: Raises £3.5M in Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

JPMorgan Pilots Software to Monitor Junior Bankers’ Working Hours

New initiative aims to enhance oversight of junior employee hours worked.Highlights: JPMorgan tests software to monitor working hours...
FinTech

Goldman Sachs to Implement Performance-Based Staff Cuts in April

The bank plans restructuring amidst shifting financial landscape.Highlights: Goldman Sachs plans performance-based staff cuts in April.The restructuring aims...
FinTech

Nasdaq Secures SEC Approval for Trading Tokenized Securities

This marks a significant advancement in digital asset trading.Highlights: Nasdaq gains SEC approval for trading tokenized securities.This approval...
FinTech

Aveni Launches Agentic AI Council to Enhance AI Ethics

New council aims to guide ethical AI development and deployment strategies.Highlights: Aveni establishes the Agentic AI Council for...